Press release
Intravenous Immunoglobulin (IVIG) Market: Rising Demand and Value Growth Trend Towards US$ 20.5 Bn by 2031 - TMR Insights
Intravenous Immunoglobulin
The IVIG market was valued at US$ 11.2 billion in 2021 and is projected to expand at a CAGR of 7.3% from 2022 to 2031. By the end of 2031, the market is expected to reach US$ 20.5 billion. The increasing adoption of IVIG therapies in treating neurological and immunodeficiency disorders is a key driver of market growth.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930
Analyst Viewpoint
Industry analysts anticipate a robust expansion in the IVIG market, driven by rising awareness of immunodeficiency treatments, increased diagnostic capabilities, and improved access to healthcare. However, challenges such as supply shortages of plasma-derived products and high treatment costs may impact market growth.
Key Market Drivers
Rising Prevalence of Immune Disorders - Increasing cases of primary and secondary immunodeficiencies boost market demand.
Advancements in Plasma Collection Technologies - Enhanced plasma fractionation techniques improve product availability.
Expanding Applications in Neurology - IVIG is increasingly used for treating neurological disorders like Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP).
Growing Geriatric Population - Aging populations with weakened immune systems drive the need for IVIG therapy.
Favorable Government Policies - Regulatory support and reimbursement policies encourage IVIG adoption.
Recent Developments
2021 - Grifols S.A. expanded its plasma collection centers to strengthen IVIG production and meet growing demand.
2022 - CSL Behring launched a new IVIG formulation aimed at enhancing patient compliance and treatment efficacy.
2023 - Takeda Pharmaceuticals announced significant investment in plasma collection and processing infrastructure to address supply constraints.
2024 - Octapharma received regulatory approval for an advanced IVIG therapy for treating autoimmune diseases.
Key Players
Baxalta Incorporated
Biotest AG
China Biologic Products, Inc.
CSL Behring LLC
Grifols S.A.
Kedrion S.p.A.
LFB Biomedicaments S.A.
Octapharma AG
Sanquin Plasma Products B.V.
Other prominent players
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930
Market Trends and Opportunities
The IVIG market is witnessing increased adoption due to its effectiveness in treating various autoimmune and neurological disorders. Technological advancements in plasma fractionation and purification are improving product efficacy and safety. Additionally, expanding research into novel applications of IVIG, such as Alzheimer's disease treatment, is creating new growth opportunities. The market is also experiencing a shift toward subcutaneous immunoglobulin (SCIG) therapy, offering better patient convenience and adherence.
Market Segmentation
Indication
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Primary Humoral Immunodeficiency
Idiopathic Thrombocytopenic Purpura (ITP)
Guillain-Barre Syndrome
Myasthenia Gravis
Multifocal Motor Neuropathy (MMN)
Kawasaki Disease
Hypogammaglobulinemia
Chronic Lymphocytic Leukemia
Others
End-user
Hospitals
Clinics
Home Care
Future Outlook
The IVIG market is set for substantial growth, driven by rising disease prevalence, improved plasma collection infrastructure, and ongoing research into new therapeutic applications. Companies investing in plasma sourcing and innovative treatment formulations will be well-positioned for success in the evolving IVIG landscape.
Regional Analysis
North America - Leads the market due to high awareness, advanced healthcare facilities, and strong industry presence.
Europe - Significant market share with increasing government initiatives supporting immunoglobulin therapies.
Asia-Pacific - Expected to witness the fastest growth due to rising healthcare investments and increasing incidence of immune disorders.
Latin America & Middle East & Africa - Emerging markets with growing demand for IVIG treatments and improving healthcare accessibility.
Explore Latest Research Reports by Transparency Market Research:
Topical Antibiotics Market: https://www.pharmiweb.com/press-release/2025-03-14/topical-antibiotics-market-to-reach-100-billion-by-2035-driven-by-51-cagr-and-innovations-in-antimicrobial-therapies-exclusive-reports-by-tmr-i
Diagnostic Specialty Enzymes Market: https://www.pharmiweb.com/press-release/2025-03-14/diagnostic-specialty-enzymes-market-to-expand-at-a-cagr-of-69-and-reach-us-18-bn-by-2035-exclusive-reports-by-tmr-insights
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin (IVIG) Market: Rising Demand and Value Growth Trend Towards US$ 20.5 Bn by 2031 - TMR Insights here
News-ID: 3943573 • Views: …
More Releases from Transparency Market Research
Paper-based Biofuel Cell Market to Reach USD 580.0 Mn by 2034, Driven by Rising …
The global Paper-based Biofuel Cell (PBFC) market is poised for substantial growth over the next decade, with its market value projected to rise from US$ 300.0 million in 2023 to US$ 580.0 million by 2034, reflecting a CAGR of 6.3% during the forecast period 2024-2034. The market is witnessing increased traction due to the expanding adoption of wearable electronic devices, rising prevalence of lifestyle diseases, and ongoing technological innovations in…
Parcel Sortation System Market Projected to Reach USD 3.1 Billion by 2034, Drive …
The global Parcel Sortation System Market is witnessing steady growth, fueled by the rapid expansion of e-commerce, the rise in online shopping, and increasing adoption of automated parcel sorting robots. Valued at US$ 2.2 billion in 2023, the market is projected to reach US$ 3.1 billion by 2034, expanding at a CAGR of 3.1% during the forecast period from 2024 to 2034.
Gain a preview of important insights from our Report…
Paresthesia Treatment Market Forecast to Reach USD 8.0 Billion by 2034, Growing …
The global Paresthesia Treatment Market is poised for steady growth over the forecast period 2024-2034, driven by rising incidence of neurological disorders, technological advancements in treatment modalities, and increasing awareness regarding early diagnosis and intervention. According to the latest industry analysis, the global paresthesia treatment market was valued at US$ 5.4 billion in 2023 and is projected to reach US$ 8.0 billion by 2034, expanding at a CAGR of 3.7%.
Gain…
Paroxysmal Nocturnal Hemoglobinuria Market Projected to Reach USD 11.7 Billion b …
The global Paroxysmal Nocturnal Hemoglobinuria (PNH) Market is poised for robust growth over the coming decade. Valued at US$ 3.8 billion in 2023, the market is projected to expand at a CAGR of 10.8% from 2024 to 2034, reaching US$ 11.7 billion by the end of 2034. The rise in geriatric population, coupled with the influx of biologics and advances in therapeutic strategies, is propelling the demand for effective management…
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends…
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,…
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary research…
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the…
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from…
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog …
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the company’s strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course of…
